Does increased 11 β HSD- 1 activity induce adverse metabolic phenotype only in lean?

Affiliations

Comment

Ravindra Shukla et al. Clin Endocrinol (Oxf). 2019 Jun.

. 2019 Jun;90(6):849.

doi: 10.1111/cen.13950. Epub 2019 Mar 7.

No abstract available

Comment in

Author's Reply: Does increased 11 β HSD-1 activity induce adverse metabolic phenotype only in lean?
Crowley RK, Woods CP, Tomlinson JW. Crowley RK, et al. Clin Endocrinol (Oxf). 2019 Jun;90(6):849-850. doi: 10.1111/cen.13964. Epub 2019 Apr 2. Clin Endocrinol (Oxf). 2019. PMID: 30828849 No abstract available.

Increased central adiposity and decreased subcutaneous adipose tissue 11β-hydroxysteroid dehydrogenase type 1 are associated with deterioration in glucose tolerance-A longitudinal cohort study.
Crowley RK, Woods CP, Hughes BA, Gray J, McCarthy T, Taylor AE, Gathercole LL, Shackleton CHL, Crabtree N, Arlt W, Stewart PM, Tomlinson JW. Crowley RK, et al. Clin Endocrinol (Oxf). 2019 Jul;91(1):72-81. doi: 10.1111/cen.13939. Epub 2019 Apr 17. Clin Endocrinol (Oxf). 2019. PMID: 30667079